Highlights in Chronic Lymphocytic Leukemia From the 65th ASH Annual Meeting and Exposition

A Review of Selected Presentations From ASH 2023  December 9-12, 2023   •   San Diego, California   Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic […]

Highlights in Metastatic Breast Cancer From the 2023 San Antonio Breast Cancer Symposium 

A Review of Selected Presentations From SABCS 2023 December 5-9, 2023  •  San Antonio, Texas   Clinical Outcomes by Age Subgroups in the Phase 3 TROPiCS-02 […]

Back to Archive